Not applicableStudy completedNCT02385604What this trial is testingThe Predictive Value of CT-PET in Esophageal CancerWho this might be right forEsophageal Neoplasms St. James's Hospital, Ireland 250
Testing effectiveness (Phase 2)Study completedNCT00118755What this trial is testingTwo Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal CancerWho this might be right forColorectal Cancer Hoffmann-La Roche 435
Testing effectiveness (Phase 2)WithdrawnNCT01174537What this trial is testingNew Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and NeuroblastomaWho this might be right forGlioblastomaSarcomaNeuroblastoma Hadassah Medical Organization
Not applicableStudy completedNCT00897533What this trial is testingDevelopment of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung CancerWho this might be right forLung Cancer ECOG-ACRIN Cancer Research Group 137
Testing effectiveness (Phase 2)Ended earlyNCT00940875What this trial is testingTarceva (Erlotinib) in Sequential Combination With Gemcitabine as First Line Therapy in Patients With Advanced Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 54
Testing effectiveness (Phase 2)Study completedNCT00520403What this trial is testingAvastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer.Who this might be right forRenal Cell Cancer Hoffmann-La Roche 25
Large-scale testing (Phase 3)Looking for participantsNCT04876651What this trial is testingThe Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care OnlyWho this might be right forMetastatic Prostate Cancer Telix Pharmaceuticals (Innovations) Pty Ltd 392
Early research (Phase 1)Looking for participantsNCT07238075What this trial is testingADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic CancersWho this might be right forAdvanced MalignancyAdvanced Solid CancersMetastatic Solid Tumors Adcytherix SAS 290
Large-scale testing (Phase 3)WithdrawnNCT01646554What this trial is testingEfficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver MetastasesWho this might be right forColorectal Cancer MetastaticLiver MetastasesKRAS Mutated Colorectal Cancer European Organisation for Research and Treatment of Cancer - EORTC
Not applicableLooking for participantsNCT04055220What this trial is testingEfficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone SarcomasWho this might be right forBone SarcomaOsteosarcomaEwing Sarcoma+4 more Centre Leon Berard 168
Not applicableStudy completedNCT02575560What this trial is testingWeekly Use First-generation EGFR-TKI in the Treatment of EGFR-TKI Acquired Resistance Non-small Cell Lung Cancer (NSCLC)Who this might be right forEGFR-TKI Resistant Mutation Qingdao Central Hospital 30
Large-scale testing (Phase 3)Study completedNCT00883779What this trial is testingTarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung CancerWho this might be right forNon-Squamous Non-Small Cell Lung Cancer Hoffmann-La Roche 451
Testing effectiveness (Phase 2)Looking for participantsNCT06532539What this trial is testingCadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial CarcinomaWho this might be right forEndometrial NeoplasmsNeoplasm Recurrence, LocalNeoplasm Metastasis Shandong Cancer Hospital and Institute 30
Testing effectiveness (Phase 2)Looking for participantsNCT05918328What this trial is testingComparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BCWho this might be right forBreast CancerHER2-positive Breast Cancer Henan Cancer Hospital 610
Large-scale testing (Phase 3)Study completedNCT00806923What this trial is testingAvastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-Squamous Non-Small Cell Lung Cancer Hoffmann-La Roche 1,044
Not applicableStudy completedNCT02135523What this trial is testingThe Efficacy of Involved-field Radiation Therapy for Residual or Locoregionally Recurrent Epithelial Ovarian Cancer After Definitive Treatment; Multi-institutional Clinical TrialWho this might be right forOvarian Cancer (Epithelial) Yonsei University 26
Testing effectiveness (Phase 2)Looking for participantsNCT06425133What this trial is testingRegorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal CancersWho this might be right forMetastatic Colorectal Cancer Centre Hospitalier Universitaire de Besancon 174
Post-approval studies (Phase 4)UnknownNCT05897749What this trial is testingClinical Study on the Effect of Brucea Javanica Oil Emulsion Injection on the Survival of Patients With Advanced Colorectal Cancer Who Failed to Receive Multi-line TreatmentWho this might be right forColorectal CancerChinese Herbal MedicineProgression-free Survival+1 more Guang'anmen Hospital of China Academy of Chinese Medical Sciences 60
Large-scale testing (Phase 3)Study completedNCT00391092What this trial is testingAvastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.Who this might be right forBreast Cancer Hoffmann-La Roche 424
Large-scale testing (Phase 3)Active Not RecruitingNCT05038735What this trial is testingStudy to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.Who this might be right forBreast Cancer Novartis Pharmaceuticals 212